ENAfter a colonoscopy finds rectal cancer, two questions come first: will I need a stoma, and can the anus be kept? In rectal cancer treatment in Germany, measurements answer them, not one surgeon’s opinion: how close the tumour sits to the sphincter, the muscle that holds stool in, and whether it has grown through the bowel wall.
This page covers the order of tests, how the plan is built and who signs it off. Outcomes and timelines are for the doctor to discuss.
Why the rectum is treated differently from the rest of the colon
The rectum sits in the narrow bony pelvis beside the bladder, the prostate or uterus and the nerves for continence and potency, so its tumours follow their own rules. A tumour counts as rectal cancer when its lower edge lies no more than 16 centimetres from the anus. Colorectal cancer treatment in Germany follows one guideline with separate rectal chapters: here radiation and drugs often precede surgery, while colon tumours are usually operated on first.
Tumour height is the distance from the tumour’s lower edge to the anus, gauged by finger during a rectal examination, measured with a rigid rectoscope and confirmed on MRI. It decides whether enough healthy tissue lies below the tumour to remove it with a margin and keep the sphincter.
Staging runs from a superficial tumour of the inner lining to growth through the wall, lymph nodes, neighbouring organs and distant metastases; the US National Cancer Institute explains each stage in plain English. Stage 4, with metastases in other organs, follows its own rules: see stage 4 colorectal cancer.
Risk rises with age, adenomatous polyps, chronic inflammatory bowel disease and bowel cancer in close relatives; Lynch syndrome and familial adenomatous polyposis are hereditary forms. Family history is taken before surgery because a hereditary form shapes the plan and follow-up, and relatives are offered genetic counselling. A test of the tumour for microsatellite instability (MSI), recommended for every new colorectal cancer, helps to flag Lynch syndrome.
Staging comes before any treatment decision
Treatment starts only when three results are in: colonoscopy histology, a pelvic MRI to the rectal protocol and a CT of chest and abdomen. The MRI shows the distance to the sphincter, growth beyond the wall, how close the tumour comes to the mesorectal fascia — the thin envelope of the rectum’s fatty tissue — and lymph node involvement; the CT looks for metastases in liver and lungs.
Early tumours also get an endorectal ultrasound, which reads the first layers of the wall better than MRI. A CEA blood test sets a baseline for follow-up; PET-CT is used only in particular situations. Screening colonoscopy and stool tests for hidden blood find polyps and early tumours before symptoms: see colonoscopy in Germany.
A multidisciplinary tumour conference (Tumorkonferenz) — colorectal surgeon, oncologist, radiation oncologist, radiologist and pathologist — reviews images and histology together; its minutes become the treatment plan. The German guideline wants every rectal cancer discussed this way before treatment; in centres certified by the German Cancer Society (Darmkrebszentrum) this is routine. The certified centre at München Klinik Neuperlach, for example, is headed by Prof. Mia Kim, also head of general and visceral surgery at München Klinik Harlaching; in Berlin, Helios Klinikum Berlin-Buch has one.
Chemoradiotherapy before surgery and saving the sphincter
In rectal cancer treatment in Germany, a middle- or lower-third tumour that has grown through the wall or reached lymph nodes is usually irradiated first, often with chemotherapy; this lowers the risk of the tumour returning in the pelvis. A short course is a few sessions of radiation alone. A long course takes several weeks alongside chemotherapy and is chosen when the tumour must shrink away from the fascia, pelvic wall or sphincter, improving the chance of keeping the anus.
At high risk — invasion of neighbouring organs, many affected nodes or a tumour against the fascia — the German S3 guideline on colorectal cancer recommends total neoadjuvant therapy (TNT): all the chemotherapy also comes before surgery. If the tumour then disappears on MRI, examination and endoscopy, the conference may offer watch and wait: surgery is deferred under strict checks and done if the tumour regrows. This suits only some patients, is offered only by experienced centres and is decided by the conference with the patient.
German clinics are frank about side effects: during radiation, tiredness builds up, the skin reddens like sunburn and stools become more frequent or loose. Pelvic radiation can reduce fertility, so freezing sperm or eggs is discussed before treatment starts.
Surgery: total mesorectal excision, robots and stomas
The core operation is total mesorectal excision (TME): the rectum is removed with its fatty envelope and lymph nodes as one intact package, never opened, sparing the pelvic nerves for bladder and sexual function. How carefully this is done governs the risk of a return in the pelvis, so the pathologist must record whether the envelope is intact.
The earliest low-risk tumours can sometimes be removed locally through the anus. More often an anterior resection removes part of the rectum and rejoins the bowel, keeping the sphincter. If the tumour reaches the sphincter, an abdominoperineal excision removes rectum and anus and leaves a permanent stoma. Tumour height, depth and sphincter function decide, not the patient’s or the surgeon’s preference.
Surgery is laparoscopic, through small incisions, or robotic, for example with the da Vinci system. The German guideline rates both as equivalent, but in a narrow pelvis the robot’s wrist-like instruments give the surgeon more freedom of movement. Robotic colon and rectal cancer surgery is done, for instance, at the robotics centre of DRK Kliniken Berlin, led by Prof. Gero Puhl; see also rectal cancer surgery.
A temporary diverting stoma protects a low join while it heals: it stays for a few months and is then closed in a smaller operation. Beforehand, the surgeon and a stoma nurse (Stomatherapeut) mark its site with the patient sitting, standing and lying; afterwards the nurse teaches the patient or a relative to change the base plate and bag, care for the skin, drink enough, adjust the diet and obtain supplies.
Recovery and follow-up
Bowel function takes months to settle after rectal surgery: stools are often frequent and fragmented, with sudden urgency, especially after stoma closure, as the remaining bowel adapts to losing its reservoir. Pelvic floor and sphincter training, biofeedback (a sensor shows the muscle’s work on a screen), diet and stool-firming medicines help, as does oncological rehabilitation. Function improves gradually; if problems persist, treatment continues.
Follow-up combines examinations, CEA tests, colonoscopy and CT or ultrasound on a schedule matched to the stage and treatment, to catch a recurrence while it can still be removed. Get the schedule in writing before discharge, since a doctor at home will carry it out. For budgeting treatment and follow-up, see cost of rectal cancer treatment.
Frequently asked questions
Can rectal cancer be cured completely?
Yes, a cure is possible, especially at an early stage; without distant metastases, treatment aims for exactly that. The chances depend on the stage, the response to radiation and chemotherapy and whether the tumour could be removed completely. Follow-up continues for several years.
Does everyone with rectal cancer need a stoma?
No. A permanent stoma is needed when the tumour reaches the sphincter or when the sphincter held stool poorly even before the illness. Otherwise the sphincter is kept, and any stoma is usually temporary: it protects the join while it heals and is closed after a few months.
Do tests done at home have to be repeated in Germany?
Not always; the clinic decides after reviewing the documents. The tumour conference needs the images on disc and the pathology reports, not just summaries. An MRI not done to the rectal protocol may have to be repeated, and the pathologist may request the biopsy blocks, for instance for MSI testing.
How AlenMed arranges treatment in Germany
AlenMed reviews reports, images and histology, matches a certified bowel cancer centre to tumour height and stage, obtains the clinic’s official cost estimate (Kostenvoranschlag), prepares visa papers, meets the patient and provides an interpreter at appointments and on the ward. The office is in Munich; partner clinics are across Germany.
This material is for information only and is not an offer. The extent of treatment and whether the sphincter can be kept are decided by a doctor after an in-person examination.
News on this topic
Charité treats first beta-thalassemia patient with CRISPR
At Berlin Charité, a 19-year-old beta-thalassemia patient became the first in Germany to receive the newly approved CRISPR gene therapy Exagamglogene Autotemcel.
Real-World Breast Cancer Study Confirms High Five-Year Survival Rates in Germany
A landmark study of over 43,000 German patients reveals a five-year invasive disease-free survival rate of 82.9 percent in early hormone receptor-positive breast cancer.
FDA Approves Jülich Diagnostic Radiotracer FET for Brain Tumor Imaging
The FDA approves the diagnostic radiotracer FET (Pixclara®) for evaluating brain gliomas, highlighting decades of neuro-oncology research at Forschungszentrum Jülich.
